Charles A. Blum

1.7k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

Charles A. Blum is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience and Sensory Systems. According to data from OpenAlex, Charles A. Blum has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Sensory Systems. Recurrent topics in Charles A. Blum's work include Ion Channels and Receptors (5 papers), Sirtuins and Resveratrol in Medicine (3 papers) and Herbal Medicine Research Studies (3 papers). Charles A. Blum is often cited by papers focused on Ion Channels and Receptors (5 papers), Sirtuins and Resveratrol in Medicine (3 papers) and Herbal Medicine Research Studies (3 papers). Charles A. Blum collaborates with scholars based in United States, United Kingdom and Australia. Charles A. Blum's co-authors include Daniel N. Cortright, A Szállaśi, Samer R. Eid, Robert Desimone, Peter A. Jacobi, Uko E. Udodong, Harry H. Wasserman, Robert B. Perni, Stéphane De Lombaert and Xiaozhang Zheng and has published in prestigious journals such as Science, Journal of the American Chemical Society and Nature Reviews Drug Discovery.

In The Last Decade

Charles A. Blum

17 papers receiving 1.2k citations

Hit Papers

The vanilloid receptor TRPV1: 10 years from channel cloni... 2007 2026 2013 2019 2007 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
    2007 689 citations A Szállaśi, Daniel N. Cortright et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles A. Blum United States 12 490 350 294 239 160 17 1.2k
Xue‐Mei Hao China 11 276 0.6× 89 0.3× 403 1.4× 12 0.1× 136 0.8× 15 1.1k
László Pecze Switzerland 18 211 0.4× 133 0.4× 251 0.9× 16 0.1× 86 0.5× 40 804
Jia‐Wei Min China 16 80 0.2× 125 0.4× 445 1.5× 22 0.1× 143 0.9× 26 1.0k
Adnan Khan Pakistan 17 67 0.1× 211 0.6× 287 1.0× 59 0.2× 51 0.3× 26 856
David F. Fitzpatrick United States 18 20 0.0× 318 0.9× 629 2.1× 93 0.4× 90 0.6× 25 1.6k
Rupinder Kaur Sodhi India 19 51 0.1× 226 0.6× 368 1.3× 45 0.2× 107 0.7× 52 979
Harshad K. Rami United Kingdom 16 390 0.8× 302 0.9× 265 0.9× 154 0.6× 116 0.7× 24 854
Umberto De Marchi Switzerland 26 24 0.0× 309 0.9× 1.2k 4.2× 82 0.3× 274 1.7× 46 1.8k
Bushra Shal Pakistan 17 59 0.1× 246 0.7× 315 1.1× 33 0.1× 46 0.3× 27 883

Countries citing papers authored by Charles A. Blum

Since Specialization
Citations

This map shows the geographic impact of Charles A. Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles A. Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles A. Blum more than expected).

Fields of papers citing papers by Charles A. Blum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles A. Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles A. Blum. The network helps show where Charles A. Blum may publish in the future.

Co-authorship network of co-authors of Charles A. Blum

This figure shows the co-authorship network connecting the top 25 collaborators of Charles A. Blum. A scholar is included among the top collaborators of Charles A. Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles A. Blum. Charles A. Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hubbard, Basil P., Hang Dai, April Case, et al.. (2013). Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators. Science. 339(6124). 1216–1219. 20 indexed citations
2.
Disch, Jeremy S., Ghotas Evindar, Cynthia H. Chiu, et al.. (2013). Discovery of Thieno[3,2-d]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3. Journal of Medicinal Chemistry. 56(9). 3666–3679. 163 indexed citations
3.
Griffith, David A., Diane M. Hargrove, Tristan S. Maurer, et al.. (2011). Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(9). 2641–2645. 21 indexed citations
4.
Hodgetts, Kevin J., Charles A. Blum, Timothy M. Caldwell, et al.. (2010). Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites. Bioorganic & Medicinal Chemistry Letters. 20(15). 4359–4363. 10 indexed citations
5.
Blum, Charles A., James L. Ellis, Christine Loh, et al.. (2010). SIRT1 Modulation as a Novel Approach to the Treatment of Diseases of Aging. Journal of Medicinal Chemistry. 54(2). 417–432. 65 indexed citations
6.
Blum, Charles A., Xiaozhang Zheng, Harry L. Brielmann, et al.. (2008). Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution. Bioorganic & Medicinal Chemistry Letters. 18(16). 4573–4577. 13 indexed citations
7.
Szállaśi, A, Daniel N. Cortright, Charles A. Blum, & Samer R. Eid. (2007). The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nature Reviews Drug Discovery. 6(5). 357–372. 689 indexed citations breakdown →
8.
Szállaśi, A, Daniel N. Cortright, Charles A. Blum, & Samer R. Eid. (2007). Erratum: The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nature Reviews Drug Discovery. 6(6). 500–500. 3 indexed citations
9.
Zheng, Xiaozhang, Kevin J. Hodgetts, Harry L. Brielmann, et al.. (2006). From arylureas to biarylamides to aminoquinazolines: Discovery of a novel, potent TRPV1 antagonist. Bioorganic & Medicinal Chemistry Letters. 16(19). 5217–5221. 25 indexed citations
10.
Blum, Charles A., Xiaozhang Zheng, & Stéphane De Lombaert. (2004). Design, Synthesis, and Biological Evaluation of Substituted 2-Cyclohexyl-4-phenyl-1H-imidazoles:  Potent and Selective Neuropeptide Y Y5-Receptor Antagonists. Journal of Medicinal Chemistry. 47(9). 2318–2325. 32 indexed citations
11.
Desimone, Robert & Charles A. Blum. (2000). Substituted 3-(2-benzoxazyl)-benzimidazol-2-(1H)-ones: A new class of GABAA brain receptor ligands. Bioorganic & Medicinal Chemistry Letters. 10(24). 2723–2726. 8 indexed citations
12.
Wasserman, Harry H. & Charles A. Blum. (1994). The chemistry of vicinal tricarbonyls. Use of vinyl and acetylenic derivatives in the synthesis of substituted indoles. Tetrahedron Letters. 35(52). 9787–9790. 22 indexed citations
13.
Wasserman, Harry H., David S. Ennis, Charles A. Blum, & Vincent M. Rotello. (1992). The conversion of car☐ylic acids to keto phosphorane precursors of 1,2,3-vicinal tricarbonyl compounds. Tetrahedron Letters. 33(40). 6003–6006. 35 indexed citations
14.
Jacobi, Peter A., Charles A. Blum, Robert Desimone, & Uko E. Udodong. (1991). Bis-heteroannulation. 15. Enantiospecific syntheses of (+)- and (-)-norsecurinine. Journal of the American Chemical Society. 113(14). 5384–5392. 54 indexed citations
15.
Jacobi, Peter A., Charles A. Blum, Robert Desimone, & Uko E. Udodong. (1991). ChemInform Abstract: Bis‐Heteroannulation. Part 15. Enantiospecific Syntheses of (+)‐ and (‐ )‐Norsecurinine.. ChemInform. 22(43). 2 indexed citations
16.
Jacobi, Peter A., Charles A. Blum, Robert Desimone, & Uko E. Udodong. (1989). Total synthesis of (+)- and (−)-norsecurinine. Tetrahedron Letters. 30(51). 7173–7176. 29 indexed citations
17.
Blum, Charles A., et al.. (1987). Improved syntheses of 6‐hydroxy‐5‐methoxy‐ and 5‐hydroxy‐6‐methoxyindoles and their O‐acetates, analogs of natural eumelanin precursors. Journal of Heterocyclic Chemistry. 24(4). 941–943. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue‐Mei Hao Breakdown of academic impact, for papers by László Pecze Breakdown of academic impact, for papers by Jia‐Wei Min Breakdown of academic impact, for papers by Adnan Khan Breakdown of academic impact, for papers by David F. Fitzpatrick Breakdown of academic impact, for papers by Rupinder Kaur Sodhi Breakdown of academic impact, for papers by Harshad K. Rami Breakdown of academic impact, for papers by Umberto De Marchi Breakdown of academic impact, for papers by Bushra Shal
Rankless by CCL
2026